Denis Chem Lab — 360° view

Denis Chem Lab, a company in the Pharmaceuticals industry, reported revenue of ₹39 crore and a net loss of ₹0.57 crore for the September 2026 quarter.

Denis Chem Lab (BSE: DENISCHEM) closed at ₹55.12 on 20 Nov 2026, down 37.1% over the past year. Its market capitalisation is ₹76 crore and it trades at 14.7 times earnings.

Share price
₹55.12 (20 Nov 2026)
Market cap
₹76 Cr (20 Nov 2026)
P/E
14.71 (20 Nov 2026)
Revenue
₹39 Cr (September 2026 quarter)
Net profit
₹-1 Cr (September 2026 quarter)
ROCE
14.0% (FY26)
ROE
9.52% (FY26)
Book value
₹64.6 (FY26)
Dividend yield
4.51% (FY26)
52-week high / low
₹91.00 / ₹54.50 (20 Nov 2026)
1-year return
-37.1% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: DENISCHEM

Incorporated in 1982, Denis Chem Lab Ltd does manufacturing of Pharmaceuticals Transfusion Solution in Bottles

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.